Novel assay for the separation and quantification of hemagglutinin antigens

Details for Australian Patent Application No. 2005223371 (hide)

Owner Crucell Holland B.V.

Inventors Lagerwerf, Fija; Kapteyn, Johan

Agent Davies Collison Cave

Pub. Number AU-B-2005223371

PCT Pub. Number WO2005/090390

Priority PCT/ EP2004/050318 17.03.04 EP

Filing date 3 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 9 June 2011

International Classifications

C07K 14/01 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/090390 Priority application(s): WO2005/090390

9 June 2011 Application Accepted

  Published as AU-B-2005223371

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223385-Process for treating a loaded solvent stream having a time-varying concentration of contaminant

2005223370-Novel heterocyclyl-substituted hydroxy6-phenylphenanthridines and their use as PDE4 inhibitors